Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication (RiScA)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to improve the prognosis of the development of alcohol consumption by considering a variety of biological, psychological and social risk and protective factors. Therefore, young people who have been hospitalized due to acute alcohol intoxication within the past 5 to 12 years will be interviewed in order to assess aspects of healthy or impaired psychosocial development. The study will also include a control group of young adults who were in hospital due to other medical conditions. The identification of relevant cases will be based on medical records of several children's hospitals. These records will be analysed with regard to potential predictors of developmental hazards and protective factors.
| Condition |
|---|
|
Alcohol Use Disorders |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Retrospective |
| Official Title: | Prediction and Detection of Intermediate and Long-term Developmental Hazards in Adolescents After Alcohol Intoxication |
- Alcohol Use Disorders [ Time Frame: 5 to 12 years ] [ Designated as safety issue: No ]Alcohol Use Disorders as measured by the The Alcohol Use Disorders Identification Test
- Self-efficacy [ Time Frame: 5 to 12 years ] [ Designated as safety issue: No ]
- Life Satisfaction [ Time Frame: 5 to 12 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 500 |
| Study Start Date: | June 2012 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Alcohol intoxicated adolescents
Adolescents who were hospitalized due to acute alcohol intoxication
|
|
Control group
adolescents who were hospitalized due to other medical conditions but not alcohol intoxication
|
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
young adults living in Germany who were hospitalized due to alcohol intoxication (experimental group) or other medical conditions (control group) 5 to 12 years ago
experimental group:
Inclusion Criteria:
- male and female volunteers who were hospitalized due to acute alcohol intoxication from January 1, 2000 to December 31, 2006
- written informed consent by the subject
- minimum age of 20 years
Exclusion Criteria:
- incapability to conduct interview
control group:
Inclusion Criteria:
- male and female volunteers who were hospitalized due to other medical conditions but not acute alcohol intoxication from January 1, 2000 to December 31, 2006
- written informed consent by the subject
- minimum age of 20 years
Exclusion Criteria:
- incapability to conduct interview
Contacts and Locations| Germany | |
| Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden | Recruiting |
| Dresden, Saxony, Germany, 01307 | |
| Contact: Ulrich Zimmermann, Dr 0049-351-4585422 Ulrich.Zimmermann@uniklinikum-dresden.de | |
| Principal Investigator: | Ulrich Zimmermann, Dr | Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden |
More Information
No publications provided
| Responsible Party: | Dresden University of Technology |
| ClinicalTrials.gov Identifier: | NCT01692054 History of Changes |
| Other Study ID Numbers: | IIA5-2511DSM220 |
| Study First Received: | August 21, 2012 |
| Last Updated: | September 21, 2012 |
| Health Authority: | Germany: Ethics Commission |
Additional relevant MeSH terms:
|
Alcohol Drinking Alcohol-Related Disorders Alcoholic Intoxication Drinking Behavior Substance-Related Disorders Mental Disorders Ethanol |
Anti-Infective Agents, Local Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Central Nervous System Depressants Physiological Effects of Drugs Central Nervous System Agents |
ClinicalTrials.gov processed this record on June 18, 2013